TAK logo

TAK

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)

$18.66
+$0.37(+2.00%)
52
Overall
60
Value
45
Tech
--
Quality
How is this score calculated?
Market Cap
$57.56B
Volume
2.60M
52W Range
$12.99 - $18.90
Target Price
$20.13

Latest News for TAK

Stifel Nicolaus Remains a Buy on Volatus Aerospace (TAKOF)
TipRanks Auto-Generated Intelligence Newsdesk3 days agoApr 06, 2026

Stifel Nicolaus analyst Greg MacDonald maintained a Buy rating on Volatus Aerospace today and set a price target of C$1.00. According to TipRanks, ......

Volatus Aerospace Posts 26% Revenue Gain as Defence Growth Transforms Balance Sheet
TipRanks Canadian Auto-Generated Newsdesk8 days agoMar 31, 2026

The latest update is out from Volatus Aerospace ( ($TSE:FLT) ). Volatus Aerospace reported fiscal 2025 revenue of C$34.2 million, a 26% year-over-y......

Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: Canadian Pacific Kansas City (CP) and Volatus Aerospace (OtherTAKOF)
Brian Anderson9 days agoMar 31, 2026

Companies in the Industrial Goods sector have received a lot of coverage today as analysts weigh in on Canadian Pacific Kansas City (CP) and Volatu......

TAKE Solutions Unveils AI-Driven Take.Health Platform for India’s Preventive Healthcare Market
TipRanks India Auto-Generated Newsdesk15 days agoMar 25, 2026

TAKE Solutions Limited ( ($IN:TAKE) ) just unveiled an update. TAKE Solutions Limited has launched Take.Health, an AI-driven digital health compani......

Takeda’s Long-Term Psoriatic Arthritis Trial Could Reshape TAK’s Immunology Outlook
TipRanks Clinical-Trials-Auto-Generated Newsdesk20 days agoMar 19, 2026

Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. The ongoing trial, “A Phase 3, Multicenter, Long-Term Ext......

Takeda Advances Dual-Therapy Ulcerative Colitis Study, Keeping Entyvio in the GI Spotlight
TipRanks Clinical-Trials-Auto-Generated Newsdesk21 days agoMar 18, 2026

Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. The phase 4 study “An Open-Label, Phase 4, Single-Arm, Mu......

Takeda’s Dual-Drug Crohn’s Study Could Reframe Entyvio’s Role in IBD Portfolios
TipRanks Clinical-Trials-Auto-Generated Newsdesk21 days agoMar 18, 2026

Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is running a Phase 4 study in adults with mo......

Takeda Tracks Real-World Safety of Alunbrig in Japanese Lung Cancer Patients
TipRanks Clinical-Trials-Auto-Generated Newsdesk22 days agoMar 17, 2026

Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda’s new post‑marketing survey, titled “General Use-r......

Takeda Tracks Real-World Safety of Alunbrig in Japanese Lung Cancer Patients
TipRanks Clinical-Trials-Auto-Generated Newsdesk22 days agoMar 17, 2026

Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda’s new post‑marketing survey, titled “General Use-r......

Takeda’s New South Korea HAE Study Aims to Cement Takhzyro’s Real World Edge
TipRanks Clinical-Trials-Auto-Generated Newsdeska month agoMar 13, 2026

Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. This post marketing study from Takeda tracks real world u......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 15 articles.

ABCD
1SymbolPriceChangeVol
2TAK$18.66+2.0%2.60M
3
4
5
6

Get Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of) Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.